Brief: Mabion Has Adopted Joint Growth Strategy To Register Mabioncd20 On Both American And European Market

Mabion SA

02/08/2021 07:27

August 2 (Reuters) - Mabion SA  MABP.WA :
    * SAID ON FRIDAY THAT IT HAS ADOPTED JOINT GROWTH STRATEGY
TO
REGISTER MABIONCD20 ON BOTH AMERICAN AND EUROPEAN MARKET
FOLLOWING TALKS WITH FDA AND EUROPEAN MEDICINES REGULATORY
BODIES
    * COMPANY HAS ESTABLISHED ITS FINAL DATA SCOPE REQUIRED TO
REGISTER AND DISTRIBUTE MABIONCD20 ON EUROPEAN MARKET    

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nEM1DJvRTa
    
 Further company coverage:  MABP.WA  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))